Biopharma Partner Services
As a leader in companion diagnostic (CDx) approvals, we are your ideal partner to help make your next breakthrough a standard of care.
Discovery & Translational Research
Our proven portfolio of high-quality comprehensive tests and our regulatory-ready dataset can accelerate clinical trial enrollment, inform trial design, or create new insights from your banked samples to discover biomarkers, identify resistance, or determine which patients could benefit from your therapy.
Clinical Development & CDx
Our FoundationOne®CDx and FoundationOne®Liquid CDx tests have 60% of all CDx approvals for NGS testing in the United States and Japan – the most of any diagnostic company
2 – and we have capabilities to develop our portfolio for the upcoming European Union In Vitro Diagnostics Regulation (EU IVDR).
Access & Commercialization
We provide broad access to precision medicine around the world, with our tests available in more than 100 countries, and offer flexible solutions to accelerate your commercial launch, such as our alert service to provide timely, de-identified alerts on biomarker populations to support marketing and sales effectiveness....
More Info Less Info